Oflicin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Oflicin

Property Description
Active Ingredient Ofloxacin
Pharmacological Class Fluoroquinolone Antibiotic
Origin Synthetic (Man-made)
Primary Forms Tablet, Topical Solution (Ophthalmic/Otic)
General Purpose Bacterial Elimination (Bactericidal)

Oflicin: A Synthetic Fluoroquinolone Antibiotic

Oflicin is a medicine available by prescription only, containing the potent active ingredient Ofloxacin, which is definitively classified as a second-generation fluoroquinolone antibiotic. This medication belongs to the broader quinolone antimicrobial agent class, used globally to combat bacterial infections. Unlike some older antibiotics derived from natural sources, Ofloxacin is a sophisticated, entirely synthetic compound, chemically engineered for anti-infective therapy. Its primary purpose is to act as an effective anti-infective agent with broad-spectrum activity, meaning it is effective against a wide variety of harmful bacteria. Ofloxacin is clinically recognized for its efficacy against both Gram-negative and Gram-positive strains.


What Forms is Ofloxacin Available In?

The core active compound, Ofloxacin, is consistently formulated as a single-ingredient product and is made available in several distinct dosage forms tailored for specific delivery. For addressing systemic, or internal, infections, the drug is typically provided as tablets intended for oral administration. Separately, to treat localized surface infections, it is prepared as a sterile solution for topical administration, specifically for ophthalmic (eye) and otic (ear) use. The chemical substance Ofloxacin is present as a racemate, meaning it contains two optical isomers, and these forms are prepared using inert pharmaceutical excipients or an appropriate aqueous base. Oflicin is often specified for situations where a versatile topical application is required, such as eliminating acute localized bacterial growth in the ear canal or eye surface.


What is the General Purpose of Oflicin?

The general purpose of Oflicin is to definitively eliminate harmful bacteria that cause infection, providing a potent solution for microbial control. The underlying principle is its inherent bactericidal effect, meaning it actively kills the target bacteria rather than just inhibiting their reproduction. The fluoroquinolone mechanism results in the destruction of susceptible microorganisms by directly interfering with vital bacterial enzymes necessary for the bacteria to maintain their DNA. By quickly stopping the bacteria’s ability to copy and repair their genetic material, Ofloxacin causes the ultimate destruction of the bacterial cell, thereby addressing the underlying cause of a bacterial invasion.

Regulatory References

  1. Ofloxacin - StatPearls - NCBI Bookshelf

What side effects are possible with Oflicin?

Possible Side Effects and Safety Information

This information is based strictly on documentation from government regulatory authorities and focuses on officially documented adverse reactions and safety restrictions associated with Oflicin.

Documented Adverse Reactions and Frequencies

Adverse reactions are classified by frequency as documented in official regulatory sources:

  • Common (may affect up to 1 in 10 people): Nausea, diarrhea.
  • Uncommon (may affect up to 1 in 100 people): Fungal infections, dizziness, headache, insomnia, vomiting.
  • Rare (may affect up to 1 in 1,000 people): Psychiatric disorders (e.g., depression, anxiety), tendon inflammation (tendinitis), muscle weakness, confusion, seizures.
  • Not Known (cannot be estimated from the available data): Serious, disabling, and potentially irreversible reactions including peripheral neuropathy (nerve damage) and tendon rupture (e.g., Achilles tendon).

Serious and Potentially Irreversible Safety Concerns

Official regulatory alerts highlight the risk of serious, disabling, and potentially irreversible adverse reactions affecting the musculoskeletal, nervous, and psychiatric systems. These reactions can occur after only a few doses and may be delayed, manifesting months after stopping the medicine. Specific serious reactions documented include:

  • Tendon Rupture and Tendinitis: Inflammation and rupture of tendons, most commonly the Achilles tendon.
  • Peripheral Neuropathy: Pain, burning, tingling, numbness, or weakness in the extremities, which can become long-lasting.
  • Central Nervous System (CNS) Effects: Including psychosis, hallucinations, and seizures.
  • Aortic Risk: Increased risk of aortic aneurysm and dissection, particularly in older patients or those with existing risk factors.

Safety Restrictions and Monitoring

Immediate discontinuation of the medicine is required at the first sign of a serious adverse reaction, such as tendon pain, joint swelling, or symptoms of nerve damage. Increased caution is officially recommended for patients over 60 years old, those with kidney impairment, or patients concurrently receiving corticosteroid medication, due to an increased risk of severe tendon effects.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation for Ofloxacin (Oflicin) outlines specific manifestations and mandatory actions required in case of overexposure or severe reactions.


Documented Overdose Manifestations

Overdose may lead to the exacerbation of known Central Nervous System (CNS) effects. Documented presentations include convulsions (seizures), toxic psychosis, tremors, restlessness, and confusion. Potential severe outcomes involve the cardiac system, specifically prolongation of the QT interval, which carries a documented risk of serious ventricular arrhythmia. Severe acute hypersensitivity reactions (e.g., anaphylaxis) are also stated as critical concerns.


Official Emergency Action and Management

Immediate medical attention must be sought if an acute overdosage is suspected or if severe CNS or cardiac symptoms occur. The regulatory procedure mandates that the patient be observed and provided with symptomatic and supportive treatment. In cases of acute overdosage, the management includes emptying the stomach (e.g., gastric lavage) and ensuring that appropriate hydration is maintained.

No specific antidote is documented in the labeling. Due to the drug's primary renal excretion, the risk of accumulation and resultant toxicity is increased in patients with impaired renal function.

Therapeutic Uses of Oflicin

What Ofloxacin Treats: Main Uses and Benefits

Ofloxacin is a prescription medication that may be part of symptomatic management for a variety of bacterial infections. Its use is applicable within clinical settings that involve acute or disruptive symptom patterns linked to susceptible bacteria. It is considered relevant for easing symptoms that become more disruptive during flare-ups across certain condition categories. This can include conditions presenting with systemic or localized discomfort linked to the urinary, respiratory, and skin and soft tissue systems, as well as sexually transmitted infections, prostatitis, and conditions affecting the eyes and ears. The medication is commonly used to help with symptoms related to inflammatory or irritative states.

In clinical scenarios where a susceptible bacterial infection produces significant symptomatic burden that interferes with daily comfort, ofloxacin helps address symptom clusters by providing support that eases the overall symptom load.

“The medication may assist with maintaining functional stability during episodes of heightened discomfort.”

Quick Fact: Supports patients during episodes of heightened discomfort.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Oflicin?

Regulatory authorities define strict population eligibility criteria for the systemic use of Oflicin (Ofloxacin), establishing specific contraindications and conditional restrictions.


Absolute Contraindications

Use of Ofloxacin is contraindicated (must not be used) in patients with a known hypersensitivity to the drug or to any other fluoroquinolone antibacterial agent. Absolute prohibitions also apply to patients with a history of tendon disorders related to any prior fluoroquinolone use, and those with known myasthenia gravis.


Age and Physiological Restrictions

Category Eligibility Rule
Pediatric Use Systemic use is generally contraindicated in children and growing adolescents.
Geriatric Use Permitted, but with special caution, particularly for patients over 60 years of age, due to an officially documented increased risk of tendon damage.
Renal Function Patients with impaired renal function (creatinine clearance le 50 mL/min) are eligible only if clearance reduction is managed.
Reproductive Status Use is generally contraindicated during pregnancy and breastfeeding by some official sources.

Conditional Use

Use is restricted in patients taking corticosteroid drugs or those with a history of organ transplants due to the elevated risk of tendon rupture. Caution is also warranted for patients with pre-existing central nervous system conditions, such as epilepsy or severe cerebral arteriosclerosis, as these may predispose to adverse events.

What should I know about interactions with other medicines?

Oflicin Interactions with other medicines and products

Interactions with Oflicin, containing the active ingredient Ofloxacin, are documented in regulatory prescribing information and primarily involve two areas: altered drug exposure and additive pharmacodynamic risks.

Documented Interaction Patterns

Mechanism / Effect Interacting Product Category Restriction or Constraint
Reduced Absorption (Chelation) Multivalent Cation-Containing Products: Antacids (Mg/Al), Iron, Zinc, Sucralfate, Didanosine (buffered/chewable). Mandatory Separation: Ofloxacin must be taken at least 2 hours before or 2 hours after these preparations to mitigate a reduction in systemic exposure.
Reduced Clearance (Active Transport) Inhibitors of Renal Tubular Secretion: Probenecid, Cimetidine, Furosemide, Methotrexate. Increased Exposure: Co-administration with Probenecid is documented to increase Ofloxacin's exposure (AUC), requiring caution.
Additive Cardiac Risk Drugs known to prolong the QT Interval: Class IA and III Antiarrhythmics, Tricyclic Antidepressants, some Macrolides. Caution Required: This combination carries a risk of QT interval prolongation, which necessitates close monitoring.
Additive CNS/Seizure Risk Theophylline, NSAIDs (e.g., Fenbufen). Increased Risk: The combination may cause a pronounced lowering of the cerebral seizure threshold.
Coagulation Potentiation Vitamin K Antagonists (e.g., Warfarin). Monitoring Required: An increased effect on coagulation parameters (e.g., PT/INR) has been reported, necessitating close monitoring of tests.

Population-Specific Interaction Notes

The co-administration of Ofloxacin with corticosteroids carries a heightened risk of tendinitis and tendon rupture, which regulatory documents note is particularly pronounced in patients over 60 years of age.

Mechanism of Action

Molecular Targeting of Bacterial DNA Gyrase and Topoisomerase IV

Ofloxacin’s action begins with the highly specific binding to two essential bacterial enzymes: DNA Gyrase and Topoisomerase IV. These targets are vital for managing the complex structure and replication of the microbial chromosome. By inhibiting the normal function of these enzymes, the drug functions to halt the fundamental bacterial DNA replication and segregation processes.


Induction of Lethal DNA Fragmentation

Once bound, Ofloxacin prevents the enzymes from resealing the DNA strands they transiently break. This locks the enzymes onto the DNA, creating a toxic complex that inflicts irreversible double-strand breaks in the bacterial genome. This mechanism rapidly leads to the active death of the microbial cell (bactericidal effect), resulting in the quick and definitive reduction of the microbial population.


️ Constraints on Mechanistic Efficacy

The mechanism is physiologically constrained by the ability of some bacteria to evolve defense strategies. Structural mutations in the enzyme targets or the presence of active efflux pumps that expel the drug can reduce its binding affinity or intracellular concentration, which in turn affects the successful completion of the bactericidal cascade.

Dosage and Administration Information

Oflicin, containing Ofloxacin, is officially administered through three distinct routes based on the infection's location: Oral (tablets), Intravenous (IV) (solution for infusion), and Topical (ophthalmic/otic solution). Systemic dosing regimens typically specify individual doses ranging between 200 mg and 400 mg, usually prescribed to be taken once daily or twice daily (every 12 hours). The total daily systemic dose is generally not to exceed 800 mg.


Oral tablets must be swallowed whole with an ample amount of liquid, and administration is allowed with or without food. Maintenance of adequate hydration is a required instruction during the course of systemic therapy. Treatment duration is precisely defined by regulatory documents, ranging from short courses of three days for specific infections to extended courses of up to six weeks for conditions like prostatitis; the total duration is advised not to exceed two months.


Dose adjustments are mandatory in specific patient populations. For patients with renal impairment (creatinine clearance <50 mL/min), a reduction in the prescribed dose is required, or the dosing interval must be extended. For intravenous administration, when used, the 400 mg dose must be infused slowly over a minimum period of 60 minutes.

Recent Clinical Evidence

Research evidence / Overview of Studies for Oflicin

The evidence for Ofloxacin comes primarily from clinical research, including Randomized Controlled Trials (RCTs) and comparative studies, as reviewed by regulatory bodies. This research examined how the medicine was studied across its approved uses, focusing on what happens during and immediately after treatment.


Evidence for Use in Systemic Infections: Urinary Tract and Prostate

The systemic (internal) use of Ofloxacin was studied for use in bacterial infections, particularly those that are conditions characterized by fluctuating or episodic manifestations.

What Researchers Studied

Researchers used controlled trials to evaluate Ofloxacin's use in conditions such as complicated and uncomplicated Urinary Tract Infections (UTIs) and Chronic Bacterial Prostatitis. The studies research examined two main types of outcomes: first, the Bacteriologic Cure Rate, which measures whether the target bacteria are cleared from the body; and second, the Clinical Cure/Success Rate, which monitors changes related to the physical signs and symptoms of the infection. These trials focused primarily on adult populations.

What the Studies Reported (Neutral Summary)

  • For UTIs, the evidence data show patterns related to bacterial clearance and symptom resolution tracked over treatment periods and in follow-up assessments. This body of evidence is broadly categorized as High in weight and consistency in scientific reviews.
  • For Chronic Bacterial Prostatitis, studies monitored responses over defined time intervals typically lasting six weeks or longer, which is a common duration for chronic conditions.

Evidence for Localized Infections: Ophthalmic and Otic Applications

The research exploring Ofloxacin’s use as a topical solution—for the eye (Ophthalmic) and ear (Otic)—is primarily derived from controlled trials.

What Researchers Studied

The research focused on localized bacterial growth, such as in bacterial conjunctivitis or certain ear infections. Trials was evaluated in specific age groups, including pediatric patients (children). The primary measurements were Microbiological Eradication Rates at the site and the Time to Resolution of local signs of infection.

What the Studies Reported (Neutral Summary)

  • Trials reported measurements of both microbiological eradication and clinical success when Ofloxacin was observed in these topical applications.
  • The evidence for topical use in both ear and eye applications is High in weight and consistency, according to regulatory documents.

What Remains Unclear: Research Gaps and Uncertainties

  • Regulatory Caution: Official regulatory bodies have advised that the systemic use of this antibiotic class may be restricted for uncomplicated infections when other treatments are available.
  • Comparative Landscape: Comparative evidence is lacking against the newest antibiotic treatments. This means the evidence highlights what is known about Ofloxacin, but direct comparative evidence is lacking against every current alternative.
  • Long-Term Effects: Long-term effects are not fully established on functional outcomes after treatment by the currently available clinical trials.

Key Studies & References

  1. Label: OFLOXACIN solution (Ophthalmic/Otic) [DailyMed / NLM]
  2. Ofloxacin Ophthalmic Solution 0.3% (Ocuflox®) Monograph

Frequently Asked Questions (FAQ)

Common questions about Oflicin (FAQ)


Q: What is the main difference between Oflicin and other similar antibiotics?

A: Oflicin (Ofloxacin) is officially classified as a second-generation fluoroquinolone antibiotic. Official product information indicates that, compared to some other medicines in this class, Ofloxacin is studied for specific bacterial infections like Chlamydia and may have a generally less significant effect on the blood levels of the medicine Theophylline.


Q: Can Oflicin cause dizziness or affect my ability to drive?

A: Regulatory documents state that Ofloxacin can cause central nervous system effects such as dizziness or blurred vision. The official guidance includes a warning to use caution when driving or operating machinery until the effects of the medicine are known.


Q: Does Oflicin interact with common pain relievers like ibuprofen or acetaminophen?

A: Ofloxacin is known to carry a risk of increased Central Nervous System (CNS) effects, including seizures, when used alongside Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen. However, no specific interaction is generally reported in regulatory documents regarding Acetaminophen (Paracetamol).


Q: Why do some people experience stomach upset with Oflicin?

A: Nausea and diarrhea are listed in official product information as common side effects. The use of antibiotics can affect the normal balance of bacteria in the gut. In rare cases, the disruption of this balance can lead to severe diarrhea associated with a condition known as colitis.


Q: Can I take Oflicin if I have a known allergy to other antibiotics?

A: Official prescribing information states that Ofloxacin is strictly contraindicated if you have a known hypersensitivity to the drug itself or to any other antibiotic that belongs to the fluoroquinolone class. Allergies to antibiotics in other classes, like penicillin, are not typically addressed as a specific contraindication in the Ofloxacin label.


Q: Can I use over-the-counter cough and cold medicine with Oflicin?

A: Specific interactions are documented with certain ingredients, such as NSAIDs and products containing metal cations, like those found in some antacids or mineral supplements. Regulatory guidance requires patients to inform their healthcare provider about the use of all over-the-counter medicines, vitamins, and supplements.


Q: Is it common for people to experience nightmares or sleep disturbances on Oflicin?

A: Yes, the official side effect profile lists trouble sleeping, or insomnia, as a potential effect related to the central nervous system. Regulatory documents also specifically note nightmares as a possible, less common central nervous system side effect.


Q: What studies exist regarding Oflicin's use in combination with other drugs?

A: The full prescribing information details a wide range of documented interactions derived from clinical investigations. These findings include warnings regarding Additive Cardiac Risk when combined with certain heart rhythm drugs, and CNS/Seizure Risk when combined with medicines like Theophylline or NSAIDs.


Q: How long does it typically take for a person to feel better after starting Oflicin?

A: For topical uses of the solution, such as in the ear (otic use), information suggests symptom improvement may be noticed during the first few days of treatment. The goal of all treatment is the reduction of physical signs and symptoms of the underlying infection.


Q: What happens if I accidentally miss a dose of Oflicin?

A: Official product guides contain instructions for managing a missed dose. These instructions typically state that if a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the instruction is to skip the missed dose and resume the regular schedule, rather than taking a double dose.


Q: Is it normal to feel tired or fatigued while taking Oflicin?

A: General fatigue is not commonly listed as a simple side effect of the medicine. However, official safety information indicates that unusual weakness or severe fatigue can be a symptom of a more serious, rare adverse event, such as liver injury or changes in blood sugar.


Q: Are there any specific foods or drinks that should be avoided while on Oflicin?

A: Regulatory information requires the medication to be taken two hours before or two hours after consuming antacids, mineral supplements, or foods/drinks that are high in calcium (like milk/dairy). This separation is necessary to prevent reduced absorption.


Q: If I stop taking Oflicin early, what could happen?

A: Regulatory documents include a warning against stopping treatment early, even if symptoms improve. This measure is in place because stopping the medicine too soon can lead to an incomplete treatment of the infection and increases the chance that bacteria will develop resistance.


Q: Can Oflicin affect birth control pills?

A: While some antibiotics may theoretically interfere with estrogen-containing hormonal contraceptives, major health authorities generally consider the risk of contraceptive failure with Ofloxacin to be low.


Q: What should I do if I develop a rash while taking Oflicin?

A: Official warnings advise that patients contact a healthcare provider right away if they develop a rash, hives, or other serious skin reactions. This immediate attention is especially important if the rash is accompanied by fever, blistering, peeling of the skin, or swelling.


Q: How quickly is Oflicin eliminated from the body?

A: Pharmacokinetic data from the full prescribing information shows that Ofloxacin has a biphasic elimination from the body. Approximately 65% to 80% of an oral dose is typically excreted unchanged by the kidneys within 48 hours.


Q: Is it true that Oflicin can increase sun sensitivity?

A: Yes, Ofloxacin can cause increased sensitivity to the sun, a condition known as photosensitivity. The official warning regarding photosensitivity includes advice to avoid prolonged sun exposure, tanning beds, and sunlamps, and to use protective clothing and sunscreen while using the medicine.


Q: Are there common signs that the antibiotic is starting to work?

A: Clinical studies track the reduction of physical signs and symptoms of the infection as the primary measure of success. For topical uses, like ear drops, official information suggests improvement may be noted during the first few days of treatment.


Q: Why is it important to complete the entire course of Oflicin even if symptoms improve?

A: Official guidance states it is essential to complete the full course as prescribed to ensure all bacteria are killed and to lower the risk of the bacteria developing resistance to Ofloxacin and similar antibiotics. This ensures the best chance of successful treatment.


Q: Can Oflicin cause temporary changes in vision?

A: Official product labeling lists visual disturbances as potential side effects. These central nervous system effects can include issues such as blurred vision and double vision (diplopia).


Q: What are the known potential interactions between Oflicin and alcohol?

A: Official product labeling includes a recommendation to limit alcoholic beverages while taking Ofloxacin. This is noted because drinking alcohol while using the medication may increase the risk of side effects like dizziness or lightheadedness.


Q: Is there a generic version of Oflicin available?

A: The active ingredient in Oflicin is Ofloxacin, which is the generic name for this medicine. It is available under various brand names and as its generic formulation.


Q: Is there a link between Oflicin and blood sugar levels?

A: Yes, official safety information indicates that Ofloxacin may cause changes to blood sugar levels. This includes a risk of both dangerously low (hypoglycemia) and high (hyperglycemia) blood sugar, especially for patients with pre-existing diabetes.


Q: How long does the effect of a single dose of Oflicin last?

A: Pharmacokinetic data from the full prescribing information provides the elimination half-life, which is the time the drug takes to be cleared from the body. The mean elimination half-life for Ofloxacin is approximately 4–5 hours in young, healthy subjects.


Q: Is it safe to exercise while taking Oflicin?

A: Due to the Boxed Warning regarding tendinitis and tendon rupture, regulatory documents emphasize caution regarding physical strain. The official guidance is to contact a healthcare provider immediately and avoid physical activity if pain, swelling, or stiffness is experienced in any tendon area.


Q: Does taking Oflicin affect caffeine metabolism?

A: Official drug interaction information includes advice to limit caffeine intake, as Ofloxacin may reduce the body's ability to metabolize caffeine. This can lead to increased effects of caffeine, such as nervousness, trouble sleeping, or rapid heartbeat.

How should Oflicin be stored and disposed of?

Storage and Handling Requirements

Ofloxacin (Oflicin) must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F). The product must be kept from freezing and protected from excessive heat and moisture, which can compromise its stability. Storage must be in a closed, tightly closed container.

Specific to the otic (ear drop) solution, the medicine must be stored with protection from light and should be warmed by hand before use to prevent temporary dizziness. All forms of Ofloxacin must be kept out of the reach of children, as required by regulatory labeling.

Official Disposal Instructions

To dispose of unused or expired Ofloxacin, it is essential to ask a healthcare professional for guidance or utilize a local drug take-back program. The medicine is not on the list of drugs recommended for disposal by flushing down a toilet or sink, and this method should be avoided. If a take-back program is unavailable, the product should be mixed with an unappealing substance, placed in a sealed bag, and discarded with household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Oflicin found in:

A-Z Index: